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Abstract
MitoNEET is a [2Fe-2S] cluster protein found on the outer mitochondrial
membrane. First discovered as a binding site for pioglitazone, an anti-diabetic drug,
it was the first protein described containing a CDGSH iron-sulfur domain (ClSD).
However, the function(s) of mitoNEET in both normal cellular physiology and the
physiology in type-2 diabetes remains unclear. The proposed functions of
mitoNEET, include cluster transfer, electron transport and oxidative respiration.
This thesis describes the use of proteomic pull-down techniques to identify possible
protein binding partners of mitoNEET from both mouse and human liver cell lysates.
In order to accomplish this, the expression and purification of mitoNEET are also
described. By analyzing the results of these pull-down experiments, we are able to
categorize possible role(s) of mitoNEET through its interaction(s) with metabolic
enzymes, proteins known to participate in cellular stress response and cancer cell
signaling.

Dedication
I dedicate this thesis to my husband, Jeff and children, Katie and Kyle.
would not have been able to accomplish this without your love, support and
personal sacrifice. I pray this represents an example of the importance of higher
education and the ability to achieve personal goals beyond anything imaginable.

ii

Acknowledgements
I would like to thank:
Dr. Konkle for giving me this incredible opportunity to work in her lab and guiding
me, step by step in the thesis process.
Dr. Burns and Dr. Methven for being a part of my committee and always being
available as a source for guidance.
Morgan Roberts for sharing her knowledge of mi to NE ET as well as being a constant
inspiration.
Sara Hughes for your moral support and keeping me focused.

iii

Table of Contents
Introduction
MitoNEET discovery .............................................................................................. 1
MitoNEET function ................................................................................................. 2
Purification by affinity chromatography ............................................................ 10

Materials and Methods
Expression and purification of mitoNEET ......................................................... 13
MitoNEET pull-down experiment.. ..................................................................... 14
Identification of pull-down proteins using proteomics .................................... 15

Results
\

Expression and purification of human mitoNEET ............................................. 18
Identification of protein binding partners of mi to NE ET .................................. 19
Proteomic results-mouse liver lysate ................................................................. 20
Proteomic results-human hepatocarcinoma cell lysate .................................... 27

Discussion
Metabolic pathways ............................................................................................. 38
Cellular stress response ....................................................................................... 41
Cell signaling cancer ............................................................................................. 42

Conclusions ............................................................................................................... ....... 43

List of Figures
Introduction
Figure 1 (A): Backbone tracing of mitoNEET protomer, (B): Ribbon diagram
of domain ................................................................................................................ 1
Figure 2: Structural comparison of mitoNEET and Miner 1.. ............................ 1
Figure 3: Spectrum of purified mitoNEET protein ............................................. 3
Figure 4: Iron-Sulfur cluster comparison of mitoNEET and Rieske .................. 3
Figure 5: Chemical structure of pioglitazone ...................................................... 5
Figure 6: Chemical structures of NAD(H) and NADP(H) .................................... 6
Figure 7: Mitochondrial matrix ............................................................................ 8
Figure 8: Glutathione-oxidized and reduced thiol group ................................... 8
Figure 9: Affinity chromatography nickel column ........................................... 11
Figure 10: Gel of purified mitoNEET from HisPur column .............................. 11

Results
Figure 11: Step gradient imidazole concentration and column volume ......... 18
Figure 12: Pull down gel results of mouse liver lysate .................................... 19
Figure 13: Pull down gel results of HepGZ lysate ............................................. 27

Discussion
Figure 14: Chemical structure of glutamate ...................................................... 39
Figure 15: Chemical structure of proline ........................................................... 39
Figure 16: Chemical structure of valine ............................................................ 39

List of Tables
Results
Table 1: Proteomic results from mouse liver Iysate sample 1.. ...................... 20
Table 2: Proteomic results from mouse liver lysate sample 2 ........................ 20
Table 3: Proteomic results from mouse liver lysate sample 3 ........................ 21
Table 4: Proteomic results from mouse liver Iysate sample 4 ........................ 25
Table 5: Proteomic results from human HepG2 lysate sample 5 .............. 27-28
Table 6: Proteomic results from human HepG2 lysate sample 6 .............. 31-32
Table 7: Proteomic results from human HepG2 lysate sample 7 .................... 35

Discussion
Table 8: Metabolic enzymes ......................................................................... 40-41
Table 9: Cellular stress response enzymes ....................................................... 42
Table 10: Cell signaling/cancer enzymes ......................................................... 42

Introduction
MitoNEET Discovery
MitoNEET is a protein discovered in 2004 that is primarily found on the
outer mitochondrial membrane (OMM) and was the first protein described as
containing a 39AA CDGSH iron-sulfur domain (CISD). (Figure 1.)
The CDGSH domain was

1

A

annotated as a zinc-finger motif and
subsequent CDGSH proteins
Cluster
Binding
Oom01in

discovered were Miner 1 (CISD2) and
Miner 2 (CISD3) in humans. 2 The
crystal structures of mitoNEET show
an intertwined homodimer with each
of the monomers containing a [2Fe-2S]

Figure 1: Structural organization ofmitoNEET.
(A)Backbone tracing of each protomer. (B) Ribbon
diagram highlighting each domain. All iron-sulfur
clusters are shown in space-filling using
colorbyatom.

cluster. The metal cluster is coordinated to the protein by 3-Cys (Cys-72, 7 4, 83)
and 1-His (His-87) residue. z
Miner 1 has a highly similar
structure to mitoNEET (Figure 2). 3 A
mutation in the Miner 1 gene, created by
the mis-splicing of mRNA that encodes
this gene, has been found to be the
Figure 2: Comparison of mitoNEET and Miner 1.3

causative agent in Wolfram Syndrome 2,

a disease characterized by juvenile onset diabetes mellitus, optic atrophy, deafness
and an increase in bleeding tendency. 3 Miner 1 was initially reported to be located

1

in the endoplasmic reticulum (ER). However a recent study showed that it is
primarily found in the outer mitochondrial membrane.

2

Miner 2, also a mitochondrial protein, has been found to contain tandem
CDGSH motifs. This is in contrast to the single CDGSH motif found in both mitoNEET
and Miner 1. The function of Miner 2, however, has not yet been described. 2
Because mitoNEET was discovered through a specific chemical probe,
a derivative of the type-2 diabetes drug pioglitazone, the function of
mitoNEET in a healthy cell and the dysfunction of mitoNEET in a cell afflicted with
type-2 diabetes are unknown. A number of possible cellular functions have been
implied from biochemical observations. The functions that led to the exploration
described in this thesis are electron transport, iron-sulfur cluster transfer,
reduction/oxidation regulation, and mediator of oxidative respiration.
Iron-sulfur clusters are protein cofactors whose primary function is electron
transport. 4 These clusters transfer electrons one at a time by alternating oxidized
(Fe+3, ferric iron) and reduced (Fe+ 2 ferrous iron) states of iron. Being consistent
with mitoNEET's role as an electron carrier, it was shown that the mitoNEET UVvisible absorption spectra changed reversibly in the oxidized and reduced states. 4
The [2Fe-2S] cluster enables us to have a spectroscopic handle that reports the
immediate environment of the cluster. Rieske proteins, and other iron-sulfur
containing proteins, are observed to have peaks in a range of (500-300nm) that are
observable in the visible region. These are assigned as ligand to metal charge
transfer (LCMT) bands.s (Figure 3.) Before the discovery of mitoNEET, the [2Fe-2S]
clusters had been categorized as being either a Rieske-type protein, that has its
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Figure 3 Spectrum ofmitoNEET protein
purified in the Konkle lab. The LMCT bands of
the oxidized protein are highlighted. (Laffoon,
Hirschfelder, Konkle, and Menze, unpublished
results

iron ligated to the histidine residue is the
iron that will become selectively reduced.

Therefore, the histidine residue plays an important role in the electron transport
properties, in enabling cluster release, and in determining redox potentiaJ.6 At low
pH, the ligating histidine residue(s) are formally uncharged. It is generally accepted
that in high-potential proteins like the Rieske,

H1s1~

His 13'

~

they deprotonate when the pH is increased,

HIS 87

y

[2Fe-2S) /

,

yielding the reduction potential in a pH-

Cys151

dependent manner.7 However, the [2Fe-2S]
clusters that are ligated by four cysteine

Cys83

1

,,

(2Fe-2$)

,

"-

Cys132

Rieske Protein Cluster

Cys74

Cysn

MrtoNEET Protein Cluster

Figure 4 Comparison of the iron-sulfur
cluster in Rieske protein and mitoNEET.

residues have pH-independent reduction
potentials, as their ligands are always negatively charged and the clusters have the
same charge as is in a fully deprotonated Rieske cluster.7
MitoNEET's unique 1-His and 3-Cys coordination of the [2Fe-2S] cluster
!ability is highly dependent on the presence of the single histidine ligand (His 87). 8
It has been shown that if the single His-87 ligand is replaced with a cysteine, the
redox potential is decreased by approximately 300 mV and the stability of the
cluster is increased by six-fold. 9 The stability of this cluster with the mutant H87C
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ligand was found to be best at pH>6. This suggests that the stability is pHdependent with regard to the protonation of His87 ligand. 9
The evidence of cluster !ability indicated that mitoNEET may function as a
iron-sulfur cluster transfer protein. Therefore, further investigations were required
to determine whether mitoNEET is capable of cluster transfer to apo-acceptor
proteins. It was reported that cluster transfer is possible between oxidized
mitoNEET and apo-ferredoxin (a-Fd) 8 and was verified through UV-VIS
spectroscopy, native-PAGE, and mitochondrial iron detections assay in cells.
His87 plays an extremely important role in cluster stability. Analysis of UVvisible spectrosopy shows that when His87 is replaced with a cysteine residue,
(H87C) inhibits cluster transfer such that it will not transfer its [2Fe-2S] cluster to
an a po-acceptor protein. This was further assessed to see if this was a result of an
increase in cluster stability from the mutant H87C. Results showed that when a
protein, KSSE, with similar kinetic stability was tested, it efficiently transferred the
[2Fe-2S] cluster to a-Fd. 8
Cluster transfer is effective, when all of the pieces fall into place. However, if
there are defects in the assembly of the cluster, there can be devastating results.
Iron is a redox active and chemically reactive atom and an important element for all
organisms to survive. Proteins have evolved that chaperone and facilitate the
transfer of iron throughout cell compartments. If this does not take place, free iron
in the system can be highly toxic. Defects in the iron-sulfur cluster assembly can
have profound impacts on cell growth, excess iron accumulation, oxidative stress,
and heme biosynthesis. 10 The assembly of proteins that have an iron-containing
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cofactor occurs mainly, but not exclusively, in the mitochondrial matrix of
eukaryotic cells.1°
Development of type-2 diabetes is associated with insulin resistance as a
result of mitochondrial dysfunction, including disrupted iron homeostasis. 11
Pharmacologic agents, such as thiazolidinedione (TZD), are commonly used to treat
this resistance. Pioglitazone, trade name Actos, is a member of the
thiozolidinedione (TZD) class of drugs that are used in the treatment of type-2
diabetes. 12 (Figure 5.) This class of drugs was approved as ligands of peroxisome
proliferator-activated receptor subtype gamma (PPAR-Y). There is evidence to
suggest that many clinical effects of TZD's originate by binding to mitoNEET. 8
Pioglitazone is known to enhance oxidative capacity and normalize metabolism by
lowering circulating lipids. Initially, these drugs were thought to operate by binding
to PPARs. Through research by JR Colca, an
additional binding site was found within the
mitochondrial membrane, and mitoNEET was
Pioglitazone

identified. 11 Pioglitazone has been shown to inhibit
Figure 5: Chemical structu re of
pioglitazone. (ChemWorks)

iron transfer from mitoNEET to mitochondria, thus

indicating it affects a specific property, the transfer of [2Fe-2S] cluster in the cell
environment. 8 MitoNEET was shown to easily transfer the [2Fe-2S] cluster to
acceptor proteins, namely apo-Ferrodoxin (a-Fd), a universal acceptor protein, only
under oxidizing conditions. 8 In in vitro experiments, it has been found that the
presence of pioglitazone increases the stability of the cluster. 10
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Another important consideration of mitochondrial and cellular redox is the
homeostasis of the molecules
NAD(H)/NADP(H). (Figure 6.) NADPH is
produced in fatty acid degradation and the citric
acid cycle. It is part of the oxidative phase of
the pentose phosphate pathway. There are
three major biological functions of NADPH. The
first is that it plays a major role in cellular anti-
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Figure 6 : Struct ures ofNAD(H) a nd
NADP(H)

oxidation system, the second is an electron source for reductive synthesis of fatty
acids, DNA and steroids, and third is that it acts as the substrate for NADPH oxidases
that play major roles in many biological and pathological pathways by generating
reactive oxygen species (ROS). 13 NAO+, like NADPH, is a coenzyme that is redox
active. NADPH is mostly found in cytosol, whereas NAO+ is found in the
mitochondria while NADPH inhibits (2Fe-2S] cluster transfer from mitoNEET to an
apo-acceptor protein, NAO+ does not cause a loss of (2Fe-2S] cluster.14 NMR titration
experiments reveal that NADPH weakly binds to mitoNEET and the clusters are
destabilized by the side chain conformation of KSS and H58 residues present in
mitoNEET. 14 Since mitoNEET has the ability to transfer its (2Fe-2S] cluster to apoacceptor proteins, it would be interesting to see what effect NADPH has on cluster
transfer. It was also found that NADPH binding to mitoNEET causes a negative shift
in the redox potential in a similar manner that was observed for TZD binding. This
suggests that His-87 is involved in the NADPH binding. 15 Although a control was
used to observe redox changes in the presence of NADH, which does not bind to
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mitoNEET, no changes were found. This suggests that the additional phosphate
group of NADPH is essential for binding NADPH to mitoNEET. 15
The redox properties of mitoNEET are pH-dependent. Research was
conducted to explore whether NADPH binding to mitoNEET affects the pH profile.
Results showed a dramatic redox shift for mitoNEET in the presence of NADPH, at
pH<7.0 and less at pH>7.0. 15 This indicated that binding NADPH shifts pKox from pH
6.8 to pH 7.8, whereas E acid shifted -40mV. The negative change was verified
through the addition of several negative charges from the phosphate groups on
NADPH. The placement of this negative charge near the [2Fe-2S) cluster
discourages further addition of negative charge that results from single electronr
reduction that results in a lower measured value for E acid. 16 It was previously
proposed that pKox is due to protonation of His-87, and results suggest that binding
of NADPH may involve His-87. 1 5 In summary, NADPH has a potential role in
regulating mitoNEETs [2Fe-2S) cluster as well as to inhibit transfer of this cluster to
apo-acceptor proteins.
Mitochondria are the powerhouses for cells. They contain two membranes,
an outer membrane and inner membrane. The membranes are separated by a small
space. The inner membrane surrounds the mitochondrial matrix where oxidative
phosphorylation takes place. (Figure 7.) Electrons are produced through the citric
acid cycle by traveling from one protein complex to the next. Oxygen is the last
recipient of electrons through this transport chain and water
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is produced. At the same time, the electron transport chain is producing ATP.
Research has shown that mitoNEET, located on the outer mitochondrial membrane,
plays an important role in
regulating electron transport
and oxidative phosphorylation.12
Analyses have shown that the
mitochondria from mitoNEETnull heart tissue of mice have
reduced oxidative capacity. It
Figure 7 : Mitochondri al matrix wi th inn er and ou ter
memb ra ne. (Google image, orego nstate.edu)

was suggested that mitoNEET is

an important iron-containing protein that is involved in the control of maximal
mitochondrial respiratory rates. It was also noted that the mechanism to achieve
this is unclear. 12
Glutathione has several important cellular roles. It is a major antioxidant in
cells, regulates the nitric oxide cycle and it is used in metabolic and biochemical
reactions such as; DNA synthesis and repair, amino acid transport, protein synthesis,
and enzyme activation.17 (Figure 8.)
protein

HS)
reduced
(free thiol)

HS~
protein

protein

)

Glutathione can be synthesized by amino acids

S oxidized

~

(disulfide)

-l

such as glycine, L-glutamic acid, and L-cysteine.
The thiol group (S-H) serves as a proton donor

protein

Figure 8: Oxidized and reduce d thiol
group in glutathione. (Stemwiki
Hyperlibrary)

and is responsible for the biological activity of
glutathione. The rate-limiting factor in

glutathione is cysteine. 18 The reduction of mitoNEET [2Fe-2S] cluster has shown to
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be accomplished by the addition of biological thiols and reversibly oxidized by
hydrogen peroxide. 19 In vitro studies show that purified mitoNEET [2Fe-2S]
clusters can be partially reduced by glutathione. 19 The clusters can be fully reduced
by dithiothreitol or the E-Coli thioredoxin/thioredoxin reductase system under
anaerobic conditions. 19 The thiol-reduced mitoNEET [2Fe-2S] clusters can be
reversibly oxidized by hydrogen peroxide. 19 This suggests that mitoNEET may act
as a sensor of oxidative signals in order to regulate mitochondrial functions through
its clusters. This does not disrupt the cluster binding of mitoNEET in vitro and in E.

coli cells.19
Studies have shown that iron-sulfur clusters in regulatory proteins can
undergo redox transition in their response to oxidative signals without disrupting
the cluster. 19 MitoNEET was put to the test by incubation with increasing
concentrations of hydrogen peroxide. Findings revealed that the clusters remained
unchanged, thus indicating their stability in the presence of hydrogen peroxide.19 In
determining whether pre-reduced mitoNEET could be oxidized by hydrogen
peroxide, experiments using prereduced mitoNEET with excess dithiothreitol under
anaerobic conditions were performed. This was done to diminish any possible
effect that NADPH would have on the mitoNEET clusters. 19 As expected, the
prereduced mitoNEET {2Fe-2S] clusters were oxidized with the addition of the
hydrogen peroxide.19
Proteins are very large biological molecules that consist of long chains of
amino acid residues. These chains differ in length and sequence, depending upon
the protein. Protein functions also vary due to their numerous roles in living
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organisms. Separation methods vary for proteins due to their amino acid sequence
and the chemical characteristics of that particular protein. These characteristics
include molecular weight, charge, solubility and biological affinity. The purification
strategy depends upon the characteristics of the target protein. Ideally, the
purification process will yield the maximum amount of target protein with
maximum loss of contaminating proteins. This process may take several steps
because of the number of other contaminating proteins that are present along with
the target protein.
One method that is used in protein purification is affinity chromatography.

(Figure 9.) Affinity chromatography is a means of separating the target protein
from the product mixture. This technique relies heavily on interaction between
molecules with a ligand bound to a matrix. One of the most commonly used affinity
techniques is the hexahistidine tag. One can add the codons for six histidines to the
end of a gene that encodes the protein of interest. After expression in bacteria, the
protein will have six extra histidine residues. Histidine contains two nitrogen atoms
that have a natural affinity for divalent cation metals. The column that is commonly
used contains a nickel (Ni 2 +) resin.
There are three steps involved in the protein purification process. The first
step is loading the protein onto the column in a buffer with a low concentration (10
mM) of imidazole. lmidazole is an organic molecule that is the same as the side
chain of histidine. The second step involves "washing" away the non-bound sample
from the support. Using appropriate buffers that will maintain the binding
interaction of the target protein and the column is extremely important in this step.
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This balance is accomplished by increasing the
concentration of imidazole to an intermediate
concentration (20 mM). The last step involves
dissociating the target protein from the
immobilized ligand using a very high
concentration of imidazole (250 mM) so that is no
longer bound and can be eluted from the column
and collected.
One of the most helpful tools in

Figure 9: Affi nity
chromatogra phy with nickel
col um n. Goo le ima es, wiki

determining the purity of the target protein

yield is through a process called denaturing gel electrophoresis (SOS PAGE, sodium
dodecyl sulfate polyacrylamide gel electrophoresis). Samples are applied to a gel
matrix and are separated by size using the application of an electric field to the
proteins that have been made linear and uniformly negative by the addition of SOS
detergent. These are then stained so the proteins can be visualized and specific
proteins can be determined according to weight. The anticipated result
of a gel after purification is that there
would only be one band, indicating the
presence of only one protein. (Figure
15kDa
JOkDa

10.)

Figure 10: Gel of purified mitoNEET
fractions from a HisPur column .
(Roberts, Hirschfelder, Konkle and
Menze, unpublished results)

Having some knowledge of
mitoNEETs functions, we hope through

expression, purificatation and protein analysis, to be able to piece together
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interactions with other proteins and learn more about the mysteries of this special
protein.
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Materials and Methods
The materials and methods were adapted from Roberts et. al. 20

Expression and Purification of MitoNEET
The plasmid containing the cleavable hexa-hjstagged mitoNEET gene in a puc
19 vector was provided by Dr. Max Funk, University of Toledo, and expressed
according to the published protocol.2 1 The culture was spun down at 10,000 RPM
for 10 minutes at 4° C and pelleted cells were red in color. The pellet was washed
with 10 mL of a phosphate buffered saline solution and centrifuged again at 10,000
RPM for 10 minutes at 4° C. Cells were re-suspended with a pre-lysis mixture of
Tris-HCI (0.05 M, pH 8.5, Fisher Bioreagents, Fairlawn, NJ), sodium chloride (0.3 M
Fisher Bioreagents, Fairlawn, NJ), imidazole (10 mJ, Sigma-Aldrich, St. Louis, MO),
BME (O.OOlµL/mL, Acros Organics, Fairlawn, NJ), DNase (20 µg/mL, Sigma-Aldrich,
St. Louis, MO), RNase (20 µg/mL, Sigma-Aldrich, St. Louis, MO), and
phenylmethylsulfonyl fluoride, (PMSF, 100 µg/mL, Sigma-Aldrich, St. Louis, MO) at
pH 8.5. The suspended cells were stored at -80° C until further purification was
required.
Chemical lysis was accomplished using lysozyme from chicken egg white (4
mg/mL, Fisher Bioreagents, Fairlawn, NJ) and triton X-100 (0.1 %, lntegra, Renton,
WA). The lysis mixture was shaken for 1hat4° C. The mixture was then spun
down at 30,000 RPM for 40 minutes at 4° C and the red-colored supernatant was
retained and stored at -80° C. A HisPur Ni-NTA chromatography cartridge
(ThermoFisher, Waltham, MA) was used with 20 mL buffer A, 4 column volumes:
50mM trisHCl, 300 mM NaCl, and 10 mM imidazole, then 20 mL buffer 8, 4 column
13

volumes: 125mM trisHCl, 750 mM NaCl, and 20 mM imidazole, and finally, 20 mL
buffer C, 4 column volumes: 125 mM trisHCl, 750 mM NaCl and 250 mM imidazole.
The column was first washed with 20 mL water, in 4 column volumes, and not
collected. 20 mL of buffer A was washed through the column and collected. (Tubes
1-3). The sample was loaded into the column, and 2 test tubes of flow through were
collected. The column was washed with 20 mL of buffer A and 7 test tubes were
collected in 3 mL fractions. 15 mL of buffer B was then washed through the column
in 3 mL fractions and 5 test tubes were collected. 30 mL of buffer C was washed
through in 1.5 mL fractions until the solution was red and then 0.5 mL fractions
were collected in approximately 21 test tubes.
The red fractions eluted from the column with the 250 mM concentration of
imidazole were analyzed by SDS-PAGE gel electrophoresis ( 4-15% TGX, Bio-Rad
Corporation, Hercules, CA). For long-term storage, purified mitoNEET was dialyzed
into 50 mM phosphate buffer at pH 8.5 immediately after elution from the column to
improve stability. The protein was stored at -80 ° C.
MitoNEET Pull-Down Experiment
A pull-down experiment using hexa-histagged mitoNEET was accomplished
using ProFound Pull-Down PolyHis Protein: Protein Interaction Kit (Thermo-Fisher,
Waltham, MA) following the manufacturer's protocol. In brief, hexa-histagged
mitoNEET, at a concentration of 19 µM was used as the "bait" protein. Two different
experiments were conducted; one using mouse liver cells as the "prey" and the other
using the human hepatocellular liver carcinoma cell line HepG2. The entire liver
was excised from a C57BL/6J black mouse immediately after the mouse was
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sacrificed. (Mouse liver supplied by Will Fernandez, Menze Laboratory, Biological
Sciences, Eastern Illinois University.) To obtain the largest quantity of cells, the
entire liver was used (-1 gram). The liver was washed with tris-buffered saline
(TBS) at pH 7.4 in order to remove excess blood and manually homogenized with an
additional 5 mL of TBS buffer on ice. The mouse liver lysate was then prepared
using a protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO) following the pulldown protocol from the homogenized mouse liver in TBS buffer supplied by the
manufacturer. The human hepatocellular liver carcinoma cell line, HepG2 (ATCC
HB-8065, Manassas, VA), was cultured to confluence (-25 million cells), trypsinized
and suspended in 5 mL of DMEM (Life Technologies, Madison, WI) and lysed
according to the manufacture's protocol to give the mammalian cell lysate.
Two controls were done for each pull-down experiment. The first control
was run with just the bait protein, mitoNEET. The second only used prey, mouse
liver lysate or HepG2 lysate. The third sample had bait and prey, mitoNEET and
either mouse liver lysate or HPG2 lysate. A SOS-PAGE gel (4-15% TG, Bio-Ra,
Hercules, CA) was run with the three different elution samples. A 37.1, 70, and 75
kDA band, unique to the bait-prey sample, was excised from both mouse and human
liver cell lysate experiments and identified.

Identification of Pull-down Proteins using Proteomics
The SOS-PAGE gel slice was divided in two. Each slice was destained and
then digested by trypsin (Promega, Madison, WI) or trypsin and GluC (Bioline,
Taunton, MA) overnight at 37° C. Digest peptides were extracted from the gel slices
with 1) 50% ACN/49.9% Hz0/0.1 % TFA and/or 2) 99.9% CAN/0.1 % TFA.
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Tryptic peptides were injected onto the C18 column using a LTA (ThermoFischer Scientific, Pittsburgh, PA) and UPLC system (Waters, Milford, MA). A
NanoAcquity UPLC® Trap Column 180µm x 20mm x 5 µm was used. Peptides were
eluted with a linear gradient from 3 to 40% acetonitrile (in water with 0.1 % formic
acid) developed over 65 minutes at room temperature, at a flow rate of 500
nL/min, and effluent was electro-sprayed into the LTQ mass spectrometer. Blanks
were run prior to the sample run to ensure there was no significant signal from the
solvents or column. Database search was carried out using SequestTM algorithms
(Proteome discoverer vl.3).
Protein annotation with proteomic identification numbers (IP numbers) and
sample number were supplied by Proteomics Center at the Indiana University
School of Medicine (Indianapolis, IN) .. Using the ID numbers from each protein
annotation, the Enzyme Commission (EC) number was searched for online, using
different protein databases including Uniprot (www.uniprot.org), Brenda
(www.brenda-enzymes.org), and Kegg (www.genome.jp/kegg/). The EC number is
a classification scheme for enzymes based on the chemical reactions they catalyze.
It is also associated with a recommended name for the respective enzyme. (ExPASy,
Bioinformatics Research Portal, www.expasy.org). There are enzymes that catalyze

several different reactions, making it difficult to assign one EC number for that
particular enzyme. There were many proteins that were not assigned EC numbers,
because not all proteins are enzymes, or had a partial number listed at this time.
Using a protein atlas from Sigma Aldrich (www.sigmaaldrich.org), as well as The
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Human Protein Atlas (www.proteinatlas.org), the EC numbers were used to find the

metabolic pathways. These pathways were noted.
Each protein found was searched in Pubmed (www.ncbi.nlm.gov/pubmed/)
via the IP number, the EC number or the protein annotation. Articles pertaining to
that particular protein were researched. Functions, descriptions or pathways of
each protein were noted.
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Results
Expression and Purification of Human MitoNEET
The plasmid containing the cleavable hexa-histagged mitoNEET was
expressed in bacterial cells. The culture was spun down and the pelleted cells were
red. The cells were re-suspended with a pre-lysis mixture of buffer (Tris-HCI), salt
(Na Cl), column ligand (imidazole ), reductant (Beta-mercaptoethanol, BME), nucleic
acid degrading enzymes (DNase, RNase) and a protease inhibitor
(phenylmethylsurfonyl fluoride) at pH 8.5. These cells were stored at -80 °C.
Chemical lysis was performed and the red colored supernatant was kept and stored
at -80°C.
MitoNEET was purified by affinity chromatography. A step-gradient of
buffers was used with a nickel chromatography cartridge. The buffers used all
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Figure 11: Method for the purification of mi to NE ET by
affinity chromatography

mM-250mM

(Figure 11.) The red
fractions were eluted from the column with the buffer containing 250 mM imidazole.
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A reducing denaturing gel of the fractions from the column indicated that

mitoNEET was pure as a single band with-12 kDa molecular weight.
Identification of Protein Binding Partners of Mi to NE ET

A pull-down

experiment was done using hexahistagged human mitoNEET.
MitoNEET was the "bait" protein and

--

Sample
1. MW Ladder
2. Wash Steps
3. Prey
,4. Bait + Prey

5. Bait

the liver lysates were the "prey".
Two controls were done for each
experiment. The first was mitoNEET,
the bait, and the second was the prey,

s
Figure 12: Pull-down gel results from the mouse liver
lysate. The molecular weight ladder is in sample 1, wash
elution steps in sample 2, th e mouse liver lysate-control
in sample 3, mitoNEET and mouse lysate in sample 4, and
the mitoNEET control in sam le 5.

mouse liver lysate. The third sample had both bait and prey. Lysates used were
either from mouse liver (courtesy of Will Fernandez, Menze lab) or from human
hepatocarcinoma cells (HepG2, courtesy of Will Fernandez, Menze Jab). The SOSPAGE gel was run to analyze the wash steps, bait-only control, prey-only control,
and bait+prey.
From the mouse samples, four bands were excised from the gel (Figure 12.)
and submitted to Indiana University School of Medicine Proteomics Center
(Indianapolis, Indiana). The bands at - 13 (Table 1.) and 26 (Table 2.) kDa were
extracted as a positive control for mitoNEET. Bands that were exclusively in the
bait-prey Jane (Figure 12, lane 4) were identified at - 70 (Table 3.) and 75 kDa
(Table 4.). Proteins in these bands were sequenced and the identification provided
by Indiana University Proteomics Center in spreadsheet form with the name of the
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protein, the proteomics ID number (IP number), and the number of peptides found.
In total 29 mouse proteins were identified.

Proteomics Results - Mouse Liver Lysate
I 1
Ta bl e 1 Proteom1c resu Its f rom sam pe
Protein
Number
1

Protein
Annotation
30S ribosomal
subunit protein
SlS [Shigella
flexneri 2a str.
2457T]

MWappt

-13 kDa

ID

EC

Number

Number

Peptides
Identified

q value

2

5.34E-06

gi:16131057

305 ribosomal subunit protein 515 [5higella flexneri 2a str. 2457T], (Table 1.

no. 1), probable bacterial contamination or misidentification.

Ta bl e 2 Proteom1c resu ts f rom samp 1e 2
Protein
Number
2
3

Protein
Annotation
Glutathione
peroxidase 1
CDGSH iron su lfur
domaincontaining protein
1

MWappt

- 24 kDa

ID

EC
Number

Peptides
Identified

q value

Number
IPI00319652.2

1.11.1.9

3

4.52E-09

2

1.39E-08

- 24 kDa
IPI00128346.1

Glutathione peroxidase 1, GPXl, (Table 2. no. 2), belongs to the group of
peroxidases that eliminate hydroperoxides. It reduces lipid hydroperoxides to their
corresponding alcohols and reduces free hydrogen peroxide to water. 22 Peroxides
are highly reactive molecules that can cause damage to proteins and DNA, therefore
GPXl protects the organism from oxidative damage. CDG5H iron sulfur domaincontaining protein 1, CI5Dl, (Table 2. no. 3), is an alternative name for mitoNEEr.12
This was a successful identification of a positive control.
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Tabl e 3 Proteom1c resu ts from samp Ie 3
Protein
Number
4
5

6
7

8
9

10
11

Protein
Annotation
Catalase
Putative
uncharacterized
protein
Carboxylesterase
3
Methylmalonatesemialdehyde
dehydrogenase
[acylating].
mitochondrial
Protein disulfideisomerase A3
Isoform 1 of 60
kDa heat shock
protein,
mitochondrial
Aldh4al protein
Heterogeneous
nuclear
ribonucleoprotein

MWapp1

ID

- 70 kDa

Number
1PJ00869393.1

- 70 kDa
- 70 kDa

13

14

15

16
17
18
19
20

21

Delta-1-pyrroline5-carboxylate
dehydrogenase,
mitochondrial
Isoform 1 of Acy!coenzyme A
synthetase
ACSMl,
mitochondrial
Glutamate
dehydrogenase 1,
mitochondrial
Amine Oxidase
[flavincontaining] 8
2-hydroxyacylCoA lyase 1
MCG23407
Calreticulin
Beta globin
Choline
dehydrogenase,
mitochondrial
lsoform 1 of NonPOU domaincontaining
octamer-binding
protein

IPJ00122815.3

Peptides
Identified
22

q value
1.28E-06

19

2.94E-07

IPJ00387289.3

3.1.1.1

13

1.28E-06

- 70 kDa

IPJ00461964.3

1.2.1.18

13

2.12E-06

- 70 kDa

IPJ00230108.6

5.3.4.l

7

2.lZE-06

1.5.1.12

7
5

l.15E-06
1.25E-06

5

1.25E-06

- 70 kDa
- 70 kDa

IPJ00308885.6
IPJ00460335.1

- 70 kDa
IPJ00620362.4

L

12

EC
Number
1.11.1.6

- 70 kDa

!PJ00405699.2

1.2.1.88

5

1.2SE-06

IPJ00126625.1

6.2.1.2

5

1.25E-06

IPJ00114209.l

1.4.1.3

5

1.25E-06

IPJ00226140.5

1.4.3.4

5

l.25E-06

kDa
kDa
kDa
kDa

IPJ00316314.1
IPJ00154043.1
IPJ00123639.l
IPJ00762198.2

4.1.-.3.1.1.88

5
4
3
2

1.25E-06
1.25E-06
1.25E-06
2.25E-06

- 70 kDa

IPJ00273146.l

1.1.99.1

2

l.15E-06

2

1.02E-06

- 70 kDa

- 70 kDa
- 70 kDa

-

70
70
70
70

- 70 kDa
IPJ00320016.7
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Catalase, CAT, (Table 3. no. 4), is a common enzyme found in almost all
living organisms exposed to oxygen. It catalyzes the decomposition of hydrogen
peroxide to oxygen and water. It thereby protects the cell from oxidative damage by
reactive oxygen species (ROS).23 Putative uncharacterized protein (Table 3. no. 5)
is a protein whose function is unknown at this time and was, therefore, not
considered in this analysis. Carboxylesterase 3, CES3, (Table 3. no. 6), is also an
enzyme involved in the decomposition of hydrogen peroxide. It protects the cell
from oxidative damage by reactive oxygen species (ROS). CES3 and CAT are usually
found in peroxisomes but have also been reported in mitochondria.23
Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial,
ALDH6A1, (Table 3. no. 7), belongs to the family of aldehyde dehydrogenases. It
plays a role in valine and pyrimidine metabolism by catalyzing the irreversible
oxidative decarboxylation of malonate and methylmalonate semialdehydes to
acetyl-and propionyl-CoA. 24 Protein disulfide-isomerase A3, PDIA3, (Table 3. no.
8), is found in the endoplasmic reticulum in eukaryotes and catalyzes the formation

and breakage of disulfide bonds between cysteine residues within proteins as they
fold. 25 It is worthwhile to note that the OMM comes into contact with the
endoplasmic recticulum. This hit is also intriguing because the crystal structures of
mitoNEET show no evidence of disulfide bond formation although the Konkle lab
identified that mitoNEET may form a disulfide bond between monomers.20
Isoform 1 of 60 kDa heat shock protein, mitochondrial, HSPDl, (Table 3. no.
9), is implicated in mitochondrial protein import and macromolecular assembly. It
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may help to prevent misfolding of proteins by promoting proper assembly of
unfolded polypeptides that are generated under stress conditions in the
mitochondrial matrix.26 This is another protein that plays a significant role in the
cell during oxidative stress. Aldh4a1, (Table 3. no. 10), is a member of the aldehyde
dehydrogenase family. It is found in the mitochondria and is an NAO-dependent
dehydrogenase that helps to catalyze the second step of the praline degradation
pathway by converting pyrroline-5-carboxylate to glutamate. 27 This action would
contribute or subtract from the amount of glutamate in the mitochondria.
Interestingly, another hit on the list, Delta-lpyrroline-5-carboxylate dehydrogenase,
mitochondrial (Table 3. no. 12), has been found to be the same enzyme as Aldh4a1.
Heterogeneous nuclear ribonucleoprotein L, HNRNPL, (Table 3. no. 11),
complexes are the structures that contain hnRNAs and their associated proteins.
They provide the substrate for the processing that pre-mRNAs undergo before
becoming functional in the cytoplasm. 28 At this time, there is no information known
about the stability or lifetime of mitoNEET mRNA. Isoform 1 of Acyl-coenzyme A
synthetase, ACSMl, (Table 3. no. 13), mitochondrial, is part of the mitochondrial
matrix and functions as a GTP-dependent lipoate-activating enzyme that generates
the substrate for lipoyltransferase. 29 Conjugated lipoyl derivatives are cofactors of a
number of enzymes.
Glutamate dehydrogenase 1, mitochondrial, GLUDl, (Table 3. no. 14), is a
mitochondrial matrix enzyme that catalyzes the oxidative deamination of glutamate
to alpha-ketoglutarate and ammonia. It also regulates amino acid induced insulin
secretion through the AMPK pathway. GLUDl is allosterically activated by ADP and
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leucine while it is inhibited by GTP and ATP. 30 Amine oxidase [flavin-containing] B,
MAOB, (Table 3. no. 15) is found in the outer mitochondrial membrane and
functions in the metabolism of neuroactive and vasoactive amines and
neurotransmitters in the central nervous system and peripheral tissues. It also
catalyzes the oxidative deamination of biogenic and xenobiotic amines. It degrades
benzylamine and phenylethylamine, normetepinephine to 4-0H-3-methoxy-Dmandelate. 3 1 2-hydroxyacyl-CoA lyase 1, HACL1, (Table 3. no. 16), is a
peroxisomal enzyme that has been found in mammals that is dependent on thiamine
pyrophosphate (TPP). It plays an important role in the degradation of 3methylbranched fatty acids and the shortening of 2-hydroxy long-chain fatty acids. 32
MCG23407, (Table 3. no. 17), has no information available at this time and was,
therefore, not considered in this analysis.
Calreticulin, CALR, (Table 3. no. 18), is a multifunctional protein that acts as
a major Ca 2 + binding (storage) protein in the lumen of the endoplasmic reticulum. It
is also found in the nucleus, suggesting it may be part of transcription regulation. 33
Beta-globin or hemoglobin, (Table 3. no. 19), probable contamination.
Choline dehydrogenase, mitochondrial, CHDH, (Table 3. no. 20), is a protein
which catalyzes the reversible conversion of choline (a neurotransmitter) to betaine
aldehyde (an intermediate in amino acid metabolism) .34 Isoform 1 of Non-POU
domain-containing octamer-binding protein, NONO, (Table 3. no. 21), is a DNA and
RNA binding protein that is involved in several nuclear processes. It binds the
conventional octamer sequence in double-stranded DNA. It also binds single-

24

stranded DNA and RNA at a site independent of the duplex site.35 It is unclear how
mitoNEET could be involved in DNA/RNA processing at this time.

Tabl e 4 Proteom1c resu ts from samp 1e 4
Protein
Number
22

23

24

2S
26

27
28

29

Protein
Annotation
Glutamate
dehydrogenase
1, mitochondrial
Aldehyde
dehydrogenase,
mitochondrial
Methylmalonatesemialdehyde
dehydrogenase
[acylating],
mitochondrial
Catalase
Serine
hydroxymethyltr
ansferase
Carboxylesterase
3
Jsoform 1 of
Dihydrolipoyllysi
ne-residue
succinyltransfera
se component of
2-oxoglutarate
dehydrogenase
complex,
mitochondrial
Dimethylaniline
monooxygenase
[N-oxideformingl 1

ID

EC

Number

Number

- 75 kDa

IPI00114209.l

- 75 kDa

Peptides
Identified

q value

1.4.1.3

SS

3.37E-06

IPI00111218.1

1.2.1.3

18

3.37E-06

- 75 kDa
- 75 kDa

IPI00461964.3
IPI00869393.l

1.2.1.27
1.11.1.6

13
7

3.31E-06
2.29E-06

- 75 kDa
- 75 kDa

IPI004S4008.l

2.1.2.1

7

2.19E-06

IPI00387289.3

3.1.1.1

4

l.19E-06

IPI00134809.2

2.3.1.61

2

2.29E-06

IPI00116432.1

1.14.13.8

2

0.0001

MWappt

- 7S kDa

- 75 kDa

Glutamate dehydrogenase 1, mitochondrial, GLUD1, (Table 4. no. 22),
duplicate, (see Table 3. no. 14). Aldehyde dehydrogenase, mitochondrial, ALDH2,

(Table 4. no. 23), is a polymorphic enzyme involved in alcohol metabolism that
catalyzes the oxidation of aldehydes to carboxylic acids.36
Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial,
MM-ALDH, (Table 4. no. 24), is an enzyme responsible for the oxidative
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decarboxylation of malonate and methylmalonate semialdehydes to acetyl-and
propionyl-CoA in the pyrimidine catabolic pathway. 37 Pyrimidine is an intermediate
in nucleic acid synthesis. Catalase (Table 4. no. 25), duplicate, (see Table 3. no. 4).
Serine hydroxymethyltransferase, SHMT2, (Table 4. no. 26), is a gene that encodes
the mitochondrial form of a pyridoxal phosphate-dependent enzyme that catalyzes
the reaction of serine and tetryhydrofolate. The encoded product is primarily
responsible for glycine, and amino acid, synthesis.38 Carboxylesterase 3 (Table 4.

no. 27), is a duplicate (see Table 3. no. 6).
Isoform 1 of Dihydrolipoyllysine-residue succinyltransferase component 2oxoglutarate dehydrogenase complex, mitochondrial, DLST, (Table 4. no. 28),
belongs to the 2-oxoacid dehydrogenase family. It catalyzes the overall conversion
of alpha-ketoglutarate to succinyl-CoA and COz.39 Dimethylaniline monooxygenase
[N-oxide-forming] 1, FM01, (Table 4. no. 29), is involved in the oxidative
metabolism of a variety of xenobiotics. The liver is the primary site for the
detoxification/metabolism of xenobiotic compounds. Form I catalyzes the Noxygenation of secondary and tertiary amines. 40
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Proteomics Results - Human Hepatocarcinoma Cell Lysate

A second pull-down experiment was done

~

I 81.11 + Pr"Y
Bait + Prey
Bait

2
J
4
.S.
6

using human hepatocarcinoma cells

l'!t)

Wash SttVS
MW Ladder

(HepG2) lysate and human mitoNEET.
Bands were selected in a similar manner as
the mouse bands (Figure 13.). The bands at

-70 (Table 6.) and 75 kDa (Table 7.) were

Figure 13 : Pull-dow n gel results from
th e HepG2 lysate. MitoNEET and HepG2
lysate in sampl e 1 and 2, th e mitoNEET
co ntrol in sample 3, th e HepG2 lysate
control in sample 4, wash elution steps in
sa mple 5, and th e molecular weight
ladder in sam le 6.

excised and submitted for proteomic analysis. However, an additional band of -37
kDa (Table 5.), that was unique to the bait-prey lane was observed and analyzed.

Proteomic Results Tables (Human)
Tabl e 5 Proteom1c resu ts f rom samp e 5
Protein
Number
1

2

3
4

5

6
7
8

9

Protein
Annotation
Glyceraldehyde3-phosphate
dehydrogenase
Aldo-keto
reductase family
1 member Cl
Isoform 2 of
Nucleophosmin
Mal ate
dehydrogenase,
mitochondrial
Fructosebiphosphate
aldolase A
Actin,
cytomplasmic 1
Qui none
oxidoreductase
Aspartate
aminotransferase,
mitochondrial
Ma late
dehydrogenase,
cytoplasmic

MWapp1

ID

EC

Number

Number

Peptides
Identified

q value

- 37 kDa

IPI00219018.7

1.2.1.12

26

O.OOE+OO

- 37 kDa

IPI00029733.1

1.1.1.-

22

1.12E-07

- 37 kDa

IPI00220740.1

12

2.33E-11

- 37 kDa

IPI00291006.2

9

2.33E-11

- 37 kDa

IPI00465439.5

7

2.38E-10

- 37 kDa

IPI00021439.1

7

1.25E-10

- 37 kDa

IPI00000792.1

1.6.99.2

5

8.70E-11

- 37 kDa

IPI00018206.3

2.6.1.1

6

O.OOE+OO

- 37 kDa

IPI00291005.8

1.1.1.37

6

1.16E-09

27

1.1.1.37

4.1.2.13

10

11
12
13
14

15

16

17
18

Similar to
nucleophosmin
Mitogen-activated
protein kinase 1
Tansaldolase
Isoform 1 of
Protein SET
DNA-(apurinic or
apyrimidinic site)
Iyase
Fructosebi phosphate
aldolase
lsoform Bl of
Heterogeneous
nuclear
ribonucleoprotein
Mitogen-activated
protein kinase 3
Aspartate
aminotransferase,
cytoplasmic

- 37 kDa

IPJ00455423.4

- 37 kDa
- 37 kDa

IPI00003479.3
IPJ00072377.1

- 37 kDa

4

3.95E-05

2.7.11.24
2.2.1.1

4
3

2.45E-05
5.61E-13

IPJ00072377.1

2.1.1.43

4

9.14E-12

- 37 kDa

IPJ00215911.3

4.2.99.18

3

7.54E-08

- 37 kDa

IPJ00418262.5

4.1.2.13

3

1.27E-06

- 37 kDa

IPJ00396378.3

4

1.31E-05

- 37 kDa

IPJ00018195.3

2.7.11.24

3

6.88E-05

- 37 kDa

IPJ00219029.3

2.6.1.1

2

6.33E-11

Glyceraldehyde-3-phosphate dehydrogenase, GADPH, (Table 5. no. 1), is a
metabolic enzyme that catalyzes the conversion of glyceraldehyde 3-phosphate to
D-glycerate 1, 3-biphosphate in glycolysis. 41 Additionally, GAPDH has been shown
to have a number of additional functions in protein expression regulation and the
progression of type-2 diabetes. Aldo-keto reductase family 1 member Cl, AKR1C1,
(Table 5. no. 2), is a member of the aldo/keto reductase superfamily. AKR1C1
catalyzes the conversion of aldehydes and ketones to their corresponding alcohols
by using NADH and/or NADPH as their cofactors. 42 •43
There are several functions of isoform 2 of nucleophosmin, NPM 1, (Table 5.
no. 3), that have been noted. One of these is a cellular process of ribosome
biogenesis, protein chaperoning, histone assembly, cell proliferation and regulation
of tumor suppressors p53/TPS3 and ARF. 44 The importance of tumor suppression
p53 in cancer progression cannot be overstated.
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Malate dehydrogenase, MDH2, (Table 5. no. 4), is an enzyme that catalyzes
the reversible oxidation of malate to oxaloacetate using the reduction of NAD+ to
NADH in the citric acid cycle in the mitochondria. 4 5 Fructose-biphosphate aldolase A,
ALDOA, (Table 5. no. 5), is a glycolytic enzyme that catalyzes the reversible
conversion of fructiose-1,6-biphosphate to glyceraldehyde 3-phosphate and
dihydroxyacetone phosphate. 46 Actin Cytoplasmic 1 (Table 5. no. 6) and quinone
oxidoreductase (Table 5. no. 7) are probable contaminats from sample handling.
Aspartate aminotransferase, mitochondrial, also called glutamic-oxaloacetic
transaminase 2, GOT2, (Table 5. no. 8), is a pyridoxal phosphate-dependent enzyme
that exists in membrane and cytoplasmic mitochondrial forms. This enzyme plays a
role in amino acid metabolism and urea and tricarboxylic acid cycles, L-aspartate to
2-oxoglutarate aminotransferase activity and L-phenylalanine to 2-oxoglutarate
aminotransferase activity. 47 Malate dehydrogenase, cytoplasmic, MDH1, (Table 5.
no. 9) catalyzes the reversible oxidation of malate to oxaloacetate utilizing the
NAD/NADH cofactor system in the citric acid cycle. 4 5 Both MDH enzymes are
involved in the malate/aspartate shuttle which enables the transport of NAD(H)
across the IMM from the cytoplasm into the mitochondrial matrix.
Nucleophosmin, NPM1, (Table 5. no. 10), has been found to be involved in
many cellular processes, such as ribosome biogenesis and transport, histone
chaperone, and genomic stability and its product is thought to be involved in the
regulation of the ARF /p53 pathway. 4 8 Mitogen-activated protein kinase 1, MAPK1,
ERK2, (Table 5. no. 11), is a member of the MAP kinase family. It is involved in a
variety of cellular processes such as proliferation, differentiation, transcription
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regulation and development. The activation of this requires phosphorylation by
upstream kinases.
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Both NMPl isoforms and MAPKl are identified as important in

carcinogenesis.
Transaldolase, TALDOl, (Table 5. no. 12), is an enzyme in the non-oxidative
phase of the pentose phosphate pathway. It provides ribose-5-phosphate for
nucleic acid synthesis and NADPH for lipid biosynthesis.
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Isoform 1 of Protein SET,

SET, (Table 5. no. 13), inhibits acetylation of nucleosome by histone acetylases
(HAT). Histone lysines which are masked from being acetylated, halt HATdependent transcription. It can also enhance DNA replication of the adenovirus
genome.
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DNA-(apurinic or apyrimidinic site(AP) lyase, APEXl, (Table 5. no. 14),

AP sites occur frequently in DNA molecules through spontaneous hydrolysis, DNA
damaging agents or glycosylases that remove the abnormal bases. It accomplishes
this by cleaving the carbon-oxygen bonds. 52
Fructose-biphosphate aldolase, ALDOC, (Table 5. no. 15), is a glycolytic
enzyme that catalyzes the reversible aldol cleavage of fructose-1,6-biphosphate and
fructose 1-phosphate to dihydroxyacetone phosphate and either glyceraldehyde-3phosphate or glyceraldehyde.
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The next proteomic hit belongs to a subfamily of

expressed heterogeneous nuclear ribonucleoproteins (hnRPs) (Table 5. no. 16).
These are RNA binding proteins and are associated with pre-mRNAs in the nucleus
and influence pre-mRNA processing and other aspects of mRNA metabolism and
transport.
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Mitogen-activated protein kinase 3, MAPK3, (Table 5. no. 17) is a member of
the MAP kinase family, also known as extracellular signal-regulated kinase (ERKs).
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It acts as a signaling cascade that regulates various cellular processes such as
proliferation, differentiation and cell cycle progression in response to a variety of
extracellular signals. It phosphorylates nuclear targets by translocating to the
nucleus by upstream kinases.
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The MAPK pathway is highly studied for its role in

carcinogenesis.
Ta bl e 6 Pro t eom1c resu Its f rom sam J.Ie 6
Protein
Number
19
20

21
22
23

24

25
26
27

28

Protein
Annotation
Protein disulfideisomerase
Glutamate
dehydrogenase 1,
mitochondrial
Retinal
dehvdrogenase 1
Calreticulin
Glucose-6phosphate
isomerase
Isoform 1 of
Polyadenylatebinding protein 1
UDP-glucose 6dehvdrogenase
Catalase
Non-POU domaincontaining
octamer-binding
protein
60 kDa heat shock
protein,
mitochondrial

ID

EC

Number

Number

- 70 kDa

IPI00010796.1

5.3.4.1

28

4.73E-06

- 70 kDa

IPI00016801.1

1.4.1.3

23

7.81E-07

- 70 kDa

IPI00218914.5

1.2.1.36

16

7.81E-07

- 70 kDa

IPI00020599.1

13

1.93E-06

- 70 kDa

IPI00908881.1

13

1.93E-06

- 70 kDa

IPI00008524.1

8

3.35E-07

- 70 kDa
- 70 kDa

IPI00008524.1
IPI00465436.4

8
8

3.35E-07
7.33E-06

- 70 kDa

IPI00304596.3

9

2.18E-05

- 70 kDa

IPI00784154.1

6

9.72E-06

- 70 kDa

IPI00221234.7

1.2.1.31

6

1.51E-06

- 70 kDa

IPI00002520.1

2.1.2.1

5

7.33E-06

IPI00217871.4

1.5.1.12
/1.2.1.8
8

4

1.llE-05

MWappt

5.3.1.9

1.1.1.22
1.11.1.6

Peptides
Identified

q value

29

30

31

aldehyde
dehydrogenase 7
family, member Al
Serine
hydroxymethyltran
sferase, mitochon.
Delta-1-pyrroline5-carboxylate
dehydrogenase,
mitochondrial

- 70 kDa

31

32

33

34
35

Iso form
Mitochondrial of
Glutathione
reductase,
Isoform alphaenolase of Alphaenolase
Isoform 2 of
Basie:in
ATP synthase
subunit alpha,
mitochondrial

- 70 kDa

IPI00016862.1

1.8.1.7

4

1.llE-05

IPI00465248.5

4.2.1.11

3

3.38E-05

- 70 kDa

IPI00019906.1

2.7.1.37

3

7.33E-06

- 70 kDa

IPI00440493.2

3.6.3.14

2

0.0002

- 70 kDa

Protein disulfide-isomerase, PDIA1, (Table 6. no. 19), is a multifunctional
protein that catalyzes the formation rearrangement and breakage of disulfide bonds
between cysteine residues within proteins as they fold.
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Glutamate dehydrogenase

1, mitochondrial, GLUD1, (Table 6. no. 20), is a mitochondrial matrix enzyme that
catalyzes the oxidative deamination of glutamate to alpha-ketoglutarate and
ammonia. It also helps regulate amino acid induced insulin secretion. It is
allosterically activated by ADP and inhibited by GTP and ATP. 30
Retinal dehydrogenase 1, ALDH1A1, (Table 6. no. 21), belongs to the
aldehyde dehydrogenase family. Aldehyde-dehydrogenase is the next enzyme after
alcohol dehydrogenase in the alcohol metabolism pathway and can convert
retinaldehyde to retinoic acid. s7 Calreticulin, CALR, (Table 6. no. 22), duplicate,
(see Table 3. no. 18). Glucose-6-phosphate isomerase, GPI, (Table 6. no. 23), is an
enzyme that catalyzes the conversion of glucose-6-phosphate to fructose-6phosphate in the second step of glycolysis.
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Isoform 1 of Polyadenylate-binding protein 1, PABPC1, (Table 6. no. 24 ),
binds to poly(A) promoting ribosome recruitment and translation initiation. It is
also required for poly(A) shortening which is the first step in mRNA decay.
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UDP-

glucose 6-dehydrogenase, UGDH, (Table 6. no. 25), converts UDP-glucose to UDPglucuronate and participates in the biosynthesis of glycosaminoglycans. These
glycosylated compounds are components of extracellular matrix and participates in
signal transduction, cell migration and cancer growth, and metastasis.

6

°Catalase,

CAT, (Table 6.no. 26) is a duplicate of the mouse results, (see Table 3. no. 4).
Non-POU domain-containing octamer-binding protein, (Table 6. no. 27),
has limited information available at this time. 60 kDa heat shock protein,
mitochondrial, HSPDl, (Table 6. no. 28), is a member of the chaperonin family. It is
essential for the folding and assembly of newly imported proteins in the
mitochondria.
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Aldehyde dehydrogenase 7 family, member Al, ALDH7 Al, (Table

6. no. 29), is a member of the aldehyde dehydrogenase (ALDH) gene family. It plays

a major role in the detoxification of aldehydes generated by alcohol metabolism and
lipid peroxidation. It also converts 2-aminoadipate semialdehyde to 2aminoadipate.
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Serine hydroxymethyltransferase, mitochondrial, SHMT2, (Table 6. no. 30),
this enzyme contributes to catalyzing the reversible, simultaneous conversions of Lserine to glycine and tetrahydrofolate to 5, 10-methylenetetrahydrofolate.
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Delta-

1 pyrroline-5-carboxylate dehydrogenase, mitochondrial, ALDH4Al, (Table 6. no.
31), belongs to the aldehyde dehydrogenase family, which catalyzes the second step

of the proline degradation pathway by converting 3-hydroxy pyrroline-5carboxylate to 4-hydroxyglutamate.
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Isoform Mitochondrial of Glutathione

reductase, mitochondrial, GSR, (Table 6. no. 32), is a homodimeric flavoprotein. It
is a central enzyme of cellular antioxidant defense and reduced oxidized glutathione
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disulfide (GSSG) to the sulfhydryl form (GSH). It is also a member of the class-1
pyridine nucleotide-disulfide oxidoreductase family.

65

lsoform one of alpha-

enolase, ENOl, (Table 6. no. 33), is a glycolytic enzyme involved in the reversible
conversion of phospo-enolpyruvate to 2-phospho-glycerate.
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Isoform 2 of Basigin,

BSG, (Table 6. no. 34), is a member of the immunoglobulin superfamily and is a
possible contaminant from sample handling.
ATP synthase subunit alpha, mitochondrial, ATPSAl, (Table 6. no. 35),
catalyzes ATP synthesis by using an electrochemical gradient of protons across the
inner membrane during oxidative phosphorylation. Composed of two linked multisubunit complexes, the soluble, catalytic core, F1 and the membrane-spanning
component, Fo, comprising the proton channel, the ATPase is the terminal enzyme in
oxidative phosphorylation.
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Ta bl e 7 Proteom1c resu ts from sam J.Ie 7
Protein
Number
36

37

38
39

40
41

42
43

44
45

46

47

47

Protein
Annotation
Isoform 1 of Heat
shock cognate 71
kDa protein
cDNA FLJ54957
highly similar to
Transketolase
Stress-70 protein,
mitochondrial
lsoform 1 of
Polyadenylatebinding proteinl
Isoform A of
Lamin-A/C
lsoform 1 of
Cytoskeletonassociated protein
4
HSPAS protein
Dolichyldiphosphooligosac
charide-protein
glycosyltransferase
subunit 1
precursor
Stress-inducedphosphoprotein 1
Isoform 1 of
Paraspeckle
component 1
cDNA FLJ78440,
highly similar to
Human lactoferrin
lsoform 1 of
Apoptosis-inducing
factor 1,
mitochondrial
lsoform 1 of
Heterogeneous
nuclear
ribonucleoprotein

Q
48
50

Apolipoprotein E
Isoform 1 of
Probably ATPdependent RNA
helicase DDXl 7

MWappt

ID

EC

Number

Number

Peptides
Identified

q value

23

1.71E-10

14

1.20E-06

- 75 kDa

IPI00003865.1

- 75 kDa

IPI00643920.3

- 75 kDa

IPI00007765.5

8

4.53e-10

- 75 kDa

IPI00008524.1

7

2.20E-12

- 75 kDa

IPI00021405.3

5

5.99E-07

- 75 kDa
- 75 kDa

IPI00141318.2
IPI00003362.2

2.7.10.1

4
3

2.02E-10
3.41E-07

- 75 kDa

2.4.99.18

3

2.55E-06

- 75 kDa

IPI00025874.2
IIPI00013894.
1

6.3.2.-

3

3.70E-07

- 75 kDa

IPI00103525.1

3

3.80E-05

- 75 kDa

IPI00298860.6

3.4.21.-

2

3.26E-07

- 75 kDa

IPI00000690.1

1.1.1.-

2

4.06E-06

- 75 kDa
- 75 kDa

IPI00018140.3
IPI00021842.1

2
2

4.62E-06
8.55E-05

- 75 kDa

IPI00023785. 7

2

0.0296
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2.2.1.1

3.6.4.13

Isoform 1 of Heat shock cognate 71 kDa protein, HSPA8, (Table 7. no. 36 ), is
a member of the heat shock protein 70 family. It is believed to function as a
chaperone and binds to nascent polypeptides to facilitate correct folding.

68

cDNA

FLJ4957, highly similar to Transketolase, TKT, (Table 7. no. 37), encodes a
thiamine-dependent enzyme which helps the channeling of excess sugar phosphates
to glycolysis in the pentose phosphate pathway. It catalyzes D-ribose-5-phosphate
to 3-phospho-glyceraldehyde.
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Stress-70 protein, mitochondrial, HSPA9, (Table 7.

no. 38), is a heat-shock cognate protein that plays a roll in cell proliferation, stress
response and maintenance of the mitochondria. It is a member of the heat shock
protein 70 family.
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Isoform 1 of Polyadenylate-binding protein 1, (Table 7. no. 39) duplicate hit,
(see Table 6. no. 24). Isoform A of Lamin-A/C, (Table 7. no. 40) is a protein of
unknown function. lsoform 1 of Cytoskeleton associated protein 4, CKAP4, (Table 7.

no. 41), mediates the anchoring of the endoplasmic reticulum to microtubules. It is
a high-affinity epithelial cell surface receptor for APF.
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HSPAS protein, (Table 7.

no. 42), is a member of the heat shock protein 70 family. Localized in the lumen of
the endoplasmic reticulum (ER), it is involved in the folding and assembly of
proteins in the ER.

72

Dolichyl-diphosphooligosaccharide-protein

glycosyltransferase subunit 1 precursor, also known as ribophorin, RPN1, (Table 7.

no. 43), is an essential subunit of the N-oligosaccharyl transferase (OST) complex
which catalyzes the transfer of a high mannose oligosaccharide from lipid-linked
oligosaccharide donor to an asparagine residue in nascent polypeptide chains.

36

73

Stress-Induced-phosphorprotein 1, STIP1, (Table 7. no. 44), is an adaptor
protein that coordinates the functions of HSP70 and HSP90 in protein folding. It is
also thought to assist in the transfer of proteins from HSP70 to HSP90 by binding
both HSP90 and substrate-bound HSP70. It stimulates the ATPase activity of HSP70
and inhibits the ATPase activity of HSP90. This suggests that it regulates both of the
conformations and the ATPase cycles of these chaperones.
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Isoform 1 of paraspeckle component 1(Table7. no. 45) and cDNA
FLJ78440, highly similar to Human lactoferrin, (Table 7. no. 46) are proteins of
unknown origin.
Isoform 1 of Apoptosis-inducing factor 1, mitochondrial, AIFM1, (Table 7.

no. 46) is a flavoprotein essential for nuclear disassembly in apoptotic cells, and is
found in the mitochondrial intermembrance space in healthy cells. It also plays a
key role in caspase-independent, pyknotic cell death in hydrogen peroxide-exposed
cells. 7 s Isoform 1 of Heterogeneous nuclear ribonucleoprotein Q, SYNCRP, (Table 7.

no. 48), belongs to the cellular heterogeneous nuclear ribonucleoprotein (hnRNP)
family. It is implicated in the mRNA processing mechanisms.
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Apolipoprotein E,

(Table 7. no. 49) and Isoform 1 of Probably ATP-ependent RNA helicase DDXl 7,
(Table 7. no. 50) resulted from probable contamination during sample handling..
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Discussion

Three separate areas were chosen to find protein interactions with
mitoNEET. These include: metabolic pathway (Table 8.), stressors (Table 9.), and
signal pathway; cancer (Table 10.). There were 50 human proteins and 29 mouse
proteins identified. Of these, 49 were excluded in the results due to duplication,
contamination, or information not being found. Interestingly, there were several
duplicates that were found not only within the same species, but in both species.
These include calreticulin, catalase, delta-1-pyrroline-5-carboxylate dehydrogenase,
glutamate dehydrogenase and serine hydroxymethyltransferase.
Glucose metabolism is responsible for producing energy for a cell.
Organisms that require oxygen to produce ATP, a coenzyme used for energy
transfer or aerobic respiration, metabolize glucose and oxygen to release energy
with byproducts of carbon dioxide and water. The conversion of glucose molecules
to pyruvate in order to obtain ATP is known as glycolysis, which mainly takes place
in the cytosol. Four proteins (Table 8.) were found to be involved in this process.
Glucose can be generated from pyruvate, in the liver, through gluconeogenesis. Five
of the proteins identified (Table 8.) were a part of this process. In the mitochondria
of aerobic organisms, energy and carbon dioxide are produced through the
oxidation of acetate that has been derived from carbohydrates and fats through the
citric acid cycle. Three of the proteins (Table 8.) are active in this pathway. In the
oxidative phosphorylation pathway, ATP is reformed through the oxidation of
nutrients found in the mitochondria. One protein (Table 8.) was found to be
involved in this process.
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Amino Acids are basic building blocks of proteins and are
classified in many different ways based on their core
structural group and side-chain groups. Functions of amino

Glutamate

acids may include neurotransmission and biosynthesis. In
Figure 14: Chemical
structure of glutamate.
Chem Works

proteins, they are the largest components of cells. Three of

the proteins found (Table 8.) are involved in amino acid biosynthesis. Glutamate
(Figure 14.) has many biochemical functions including

cellular energy and protein synthesis. It can also be used
as a nitrogen donor in anabolic processes. Proline (Figure

15.) is an amino acid that the body can synthesize that is

OJ-OH

CNH
Proline

derived from L-glutamate. It is commonly found in the

CH 3 0

H3cVoH
NH 2
Valine
Figure 16: Chemical
structure ofvaline.
Chem Works

secondary structures, the alpha

Figure 15: Chemical
structure of pro line.
Chem Works.

helices and beta sheets. It is a DNA-encoded amino acid.
Valine (Figure 16.) is an essential, branch-chain amino acid
that is involved in protein building and helps to repair
damaged tissues. Methylmalonate-semialdehyde

dehydrogenase [acylating], mitochondrials plays a role in valine metabolism.
Carbohydrate biosynthesis (Table 8.) is simply producing carbohydrates
from the chemical reactions and metabolic pathways. In this particular case, being
similar to transketolase, the pentose phosphate pathway would be involved.
Choline degredation (Table 8.), through choline dehydrogenase, is involved
in many pathways. It is also involved in gene expression through DNA methylation.
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Catecholamines (Table 8.) are derived from the amino acid tyrosine. Amine
oxidase functions in the metabolism of vasoactive amines and some are bound to
plasma proteins in the bloodstream. Retinal metabolism (Table 8.), which retinal
dehydrogenase is a cofactor binds free retinal and cellular retinal-binding proteinbound retinal. Folic acid pool (Table 8.) are involved in the transfer of 1 carbon
units by using serine hydroxymethyltransferase.
Table 8 Metabolic Enzymes
Name
Malate dehydrogenase,
mitochondrial, cytoplasamic
Glyceraldehyde-3-phosphate
dehydrogenase
Fructose-biphosphate
al do lase
Aldehyde dehydrogenase
mitochondrial
lsoform alpha-enolase of
Alpha enolase
Glutamate dehydrogenase 1,
mitochondrial

E.C.Number
1.1.1.37
1.2.1.12
4.1.2.13
1.2.1.3
4.2.1.11

1.4.1.2
Aspartate aminotransferase,
mitochondrial, cytoplasmic
2.6.1.1
ATP synthase subunit alpha,
mitochondrial
ALDH4Al
Delta-1-pyrroline-5carboxylate dehydrogenase,
mitochondrial
Methylmalonatesemialdehyde
dehydrogenase [acylating],
mitochondrial
Choline dehydrogenase,
mitochondrial
cDNA FLJ54957, highly
similar to Transketolase

3.6.3.14

Metabolic Pathwav
Citric Acid Cycle
Gluconeogenesis
Glycolysis and
Gluconeogenesis
Glycolysis and
Gluconeogenesis
Glycolysis and
Gluconeogenesis
Glycolysis and
Gluconeogenesis
Citric Acid Cycle and
Amino Acid Biosynthesis
(e:lutamate)
Citric Acid Cycle and
Amino Acid Biosynthesis
(glutamate)
Oxidative
phosphorylation
Amino Acid Biosynthesis
(praline)

1.5.1.12
Amino Acid Biosynthesis
(valine)
1.2.1.18
Choline degradation
1.1.99.1
2.2.1.1
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Carbohydrate
biosynthesis

UD P-glucose-6dehvdrogenase
Amine oxidase [flavincontainin~l B
Retinal Dehvdrogenase 1
Serine
hydroxymethyltransferase,
mitochondrial

1.1.1.22

Carbohydrate
biosvnthesis

1.4.3.4
1.2.1.36

Catecholamines
Retinol metabolism

2.1.2.1

Folic Acid Pool

Protein folding involves many enzymes and chaperones in order to regulate
reactions. Two of the most important are disulfide bond formation and N-linked
glycosylation. The endoplasmic reticulum recognizes when a misfolding occurs and,
without disruption to the ER, will guide the misfold through ER
degradation 77 (Table 9.). Catalase and glutathione peroxidase (Table 9.) protect the
organism from oxidative damage. 22 Formation of hydrogen peroxide or larger
molecules, hydroperoxides, can be very harmful to cells.
A mutation in the aldehyde dehydrogenase 7-family (Table 9.) has been
known to cause phydridoxine-dependent epilepsy. 62 This mutation causes the
production of a nonfunctional antiquitin protein. A shortage of this protein can
cause a disruption in pyridoxine activity, which plays a role in many processes such
as the breakdown of amino acids in the body.
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Table 9 Cellular Stress Response
Name
Calreticulin
Catalase
Glutathione peroxidase
60 kDa heat shock protein,
mitochondrial
Isoform 1 of heat shock cognate 71 kDa
protein
HSPAS protein
Stress-70 protein, mitochondrial
Aldehyde dehydrogenase 7 family,
member Al
Isoform Mitochondrial of Glutathione
reductase, mitochondrial

Stressor
Misfolded proteins
H202
H202/hydroperoxides
Misfolded proteins
Misfolded proteins
Misfolded proteins
Misfolded proteins
Pyridoxine-dependent
Thioredoxin system-absence of
glutathione reductase

Data indicates mitoNEETs possible interaction with cancer cell signaling
pathways (Table 10.). These include possible promotion of tumor growth, gene
mutation and binding disruption. Their pathways neatly fit into cancer hallmark
categories of sustaining proliferative signaling, evading growth suppressors,
activating invasion and metastasis, enabling replicative immortality, inducing
angiogenesis and resisting cell death. 78
Table 10 Cell Signaling/Cancer
Name
lsoform 2 of nucleophosmin
Mitogen-activated protein kinase 1
Mitogen-activated protein kinase 3
lsoform 1 of polyadenylate-binding
protein 1
Isoform 1 of protein SET

SiJznal Pathwav
Ribosome biogenesis protein
MAPK's growth signaling
MAPK's growth signaling
Mistranslation initiation
Apoptosis
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Conclusion

We found that the plot of the mystery of mitoNEET's function(s) only
thickens. The observations that mitoNEET is a binding site for pioglitazone, has the
ability to transfer the [2Fe-2S] cluster, participate in electron transport, and
regulate oxidative respiration are helpful. However, the mechanisms of these
functions and their role in the cellular physiology remain unclear. Our pull-down
experiments indicate that mitoNEET may have interaction(s) with metabolic
pathway proteins, stress proteins and proteins involved in cancer cell signaling are
promising.
Characterizing proteins often requires the process of protein purification,
which is a painstaking task that involves many steps and trials to optimize. Certain
procedures are available in order to succeed in this endeavor. Persistence and
patience become part of the overall process because it is very difficult to isolate
certain proteins that are to be analyzed. Assays and analytical procedures are
performed in order to quantitatively and qualitatively assess the target protein.
Purified products need verification in order to ensure the correct protein has been
isolated and identified.
Through our pull down experiments and proteomic verification, we were
able to determine protein binding partners of mitoNEET. Having verified the
positive hit of glutamate dehydrogenase 1, we are one step closer to unraveling the
the function(s) of mitoNEET and have shown that our pull-down results provide a
solid experimental foundation.

43

References
(1)

Wiley, S. E.; Paddock, M. L.; Abresch, E. C.; Gross, L.; van der Geer, P.;

Nechushtai, R.; Murphy, AN.; Jennings, P. A; Dixon, J. E.j. Biol. Chem. 2007, 282,

23745-23749.
(2)

Lin, J.; Zhang, L.; Lai, S.; Ye, K. PloS one 2011, 6.

(3)

Conlan, AR.; Axelrod, H. L.; Cohen, A E.; Abresch, E. C.; Zuris, J.; Yee, D.;

Nechushtai, R.; Jennings, P. A; Paddock, M.
(4)

L.f. Mo!.

Biol. 2009, 392, 143-153.

Lin, J.; Zhou, T.; Ye, K.; Wang, J. Proc. Natl. Acad. Sci. United States Am. 2007,

104, 14640-14645.

(5)

Konkle, M. E.; Muellner, S. K.; Schwander, A L.; Dicus, M. M.; Pokhrel, R.; Britt,

R. D.; Taylor, A. B.; Hunsicker-Wang, L. M. Biochemistry 2009, 48, 9848-9857.
(6)

Dicus, M. M.; Conlan, A; Nechushtai, R.; Jennings, P. A; Paddock, M. L.; Britt, R.

D.; Stoll, S.j. Am. Chem. Soc. 2010, 132, 2037-2049.
(7)

Zu, Y.; Couture, M. M.-J.; Kolling, D.R. J.; Crofts, AR.; Eltis, L. D.; Fee, J. A; Hirst,

J. Biochemistry 2003, 42, 12400-12408.
(8)

Zuris, J. A; Harir, Y.; Conlan, AR.; Shvartsman, M.; Michaeli, D.; Tamir, S.;

Paddock, M. L.; Onuchic, J. N.; Mittler, R.; Cabantchik, Z. I.; Jennings, P. A; Nechushtai,
R. Proc. Natl. Acad. Sci. United States Am. 2011, 108, 13047-13052.
(9)

Conlan, A R.; Paddock, M. L.; Homer, C.; Axelrod, H. L.; Cohen, A E.; Abresch, E.

C.; Zuris, J. A; Nechushtai, R.; Jennings, P. A Acta Crystallogr. Sect. Biol. Crystallogr.

2011, 67, 516-523.
(10)

Paddock, M. L.; Wiley, S. E.; Axelrod, H. L.; Cohen, A E.; Roy, M.; Abresch, E. C.;

Capraro, D.; Murphy, A N.; Nechushtai, R.; Dixon, J. E.; Jennings, P. A Proc. Natl. Acad.

44

Sci. United States Am. 2007, 104, 14342-14347.

(11)

Colca, J. R.; McDonald, W. G.; Waldon, D. J.; Leone, J. W.; Lull, J.M.; Bannow, C.

A; Lund, E.T.; Mathews, W.R. Am.]. Physiol. Endocrinol. Metab. 2004, 286, E252E260.
(12)

Wiley, S. E.; Murphy, A. N.; Ross, S. A; van der Geer, P.; Dixon, J.E. Proc. Natl.

Acad. Sci. United States Am. 2007, 104, 5318-5323.

(13)

Ying, W. Antioxidants &amp; redox Signal. 2008, 10, 179-206.

(14)

Zhou, T.; Lin, J.; Feng, Y.; Wang, J. Biochemistry 2010, 49, 9604-9612.

(15)

Zuris, J. A; Ali, S.S.; Yeh, H.; Nguyen, T. A; Nechushtai, R.; Paddock, M. L.;

Jennings, P.A.]. Biol. Chem. 2012, 287, 11649-11655.
(16)

Karagas, N. E.; Jones, C. N.; Osborn, D. J.; Dzierlenga, A. L.; Oyala, P.; Konkle, M.

E.; Whitney, E. M.; David Britt, R.; Hunsicker-Wang, L. M.j. Biol. Jnorg. Chem. :]BJC:
Pub/. Soc. Biol. Inorg. Chem. 2014.

(17)

Scholz, R. W.; Reddy, P. V.; Wynn, M. K.; Graham, K. S.; Liken, A. D.; Gumpricht,

E.; Reddy, C. C. Free. Radie. Biol. &amp; Med. 1997, 23, 815-828.
(18)

Pompella, A; Visvikis, A; Paolicchi, A; De Tata, V.; Casini, A. F. Biochem.

Pharmacol. 2003, 66, 1499-1503.

(19)

Landry, A. P.; Ding, H. Redox control of human mitochondrial outer

membrane protein MitoNEET [2Fe-2S] clusters by biological thiols and hydrogen
peroxide. The journal of biological chemistry, 2014, 289, 4307-4315.
(20)

Roberts, M. E.; Crail, J. P.; Laffoon, M. M.; Fernandez, W. G.; Menze, M. A;

Konkle, M. E. Biochemistry 2013, 52, 8969-8971.
(21)

Arif, W.; Xu, S.; lsailovic, D.; Geldenhuys, W. J.; Carroll, R. T.; Funk, M. 0.

45

Biochemistry 2011, 50, 5806-5811.

(22)

Handy, D. E.; Lubos, E.; Yang, Y.; Galbraith, J. D.; Kelly, N.; Zhang, Y.-Y.; Leopold,

J. A; Loscalzo, J.f. Biol. Chem. 2009, 284, 11913-11921.
(23)

Mueller, S.; Riedel, H. D.; Stremmel, W. Blood 1997, 90, 4973-4978.

(24)

Talfournier, F.; Stines-Chaumeil, C.; Branlant, G.j. Biol. Chem. 2011, 286,

21971-21981.
(25)

Tamang, D. L.; Alves, B. N.; Elliott, V.; Redelman, D.; Wadhwa, R.; Fraser, S. A;

Hudig, D. Cell. Immunol. 2009, 255, 82-92.

(26)

Giilden, E.; Marker, T.; Kriebel, J.; Kolb-Bachofen, V.; Burkart, V.; Habich, C.

FEBS Lett. 2009, 583, 2877-2881.

(27)

Pemberton, T. A; Tanner, J.

J. Arch. Biochem. Biophys. 2013, 538, 34-40.

(28)

Chiou, N.-T.; Shankarling, G.; Lynch, K. W. Mo/. cell 2013, 49, 972-982.

(29)

Fujino, T.; Takei, Y. A; Sone, H.; Ioka, R. X.; Kamataki, A; Magoori, K.;

Takahashi, S.; Sakai, J.; Yamamoto, T. T.]. Biol. Chem. 2001, 276, 35961-35966.

(30)

Shashidharan, P.; Plaitakis, A Neurochem. Res. 2014, 39, 460-470.

(31)

Orru, R.; Aldeco, M.; Edmondson, D. E.j. Neural Transm. 2013, 120, 847-851.

(32)

Casteels, M.; Sniekers, M.; Fraccascia, P.; Mannaerts, G. P.; Van Veldhoven, P. P.

Biochem. Soc. Trans. 2007, 35, 876-880.

(33)

Michalak, M.; Mariani, P.; Opas, M. Biochem. cell Biol.

=Biochim. et Biol. Cell.

1998, 76, 779-785.
(34)

Kumar, J.; Garg, G.; Kumar, A; Sundaramoorthy, E.; Sanapala, K. R.; Ghosh, S.;

Karthikeyan, G.; Ramakrishnan, L.; Sengupta, S. Circ. Cardiovasc. Genet. 2009, 2, 599-

606.

46

(35)

Clark, J.; Lu, Y.

J.; Sidhar, S. K.; Parker, C.; Gill, S.; Smedley, D.; Hamoudi, R.;

Linehan, W. M.; Shipley, J.; Cooper, C. S. Oncogene 1997, 15, 2233-2239.

(36)

Murata, C.; Watanabe, T.; Furuya, H.; Sugioka, Y.; Mikurube, H.; Yokoyama, A;

Atsumi, Y.; Matsuoka, K.; Okazaki, I. Metab. Clin. Exp. 2003, 52, 1096-1101.

(37)

Sokatch, J. R.; Sanders, L. E.; Marshall, V. P.]. Biol. Chem. 1968, 243, 2500-

2506.
(38)

Chitnumsub, P.; lttarat, W.; Jaruwat, A; Noytanom, K.; Amornwatcharapong,

W.; Pornthanakasem, W.; Chaiyen, P.; Yuthavong, Y.; Leartsakulpanich, U. Acta

Crystallogr. Sect. Biol. Crystallogr. 2014, 70, 1517-1527.

(39)

Habelhah, H.; Laine, A; Erdjument-Bromage, H.; Tempst, P.; Gershwin, M. E.;

Bowtell, D. D. L.; Ronai, Z.]. Biol. Chem. 2004, 279, 53782-53788.

(40)

Zhang, J.; Cerny, M. A; Lawson, M.; Mosadeghi, R.; Cashman, J. R.]. Biochem.

Mo/. Toxicol. 2007, 21, 206-215.

(41)

Takaoka, Y.; Goto, S.; Nakano, T.; Tseng, H.-P.; Yang, S.-M.; Kawamoto, S.; Ono,

K.; Chen, C.-L. Sci. reports 2014, 4.

(42)

Jung, K.-A.; Choi, B.-H.; Nam, C.-W.; Song, M.; Kim, S.-T.; Lee, J. Y.; Kwak, M.-K.

Toxicol. Lett. 2013, 218, 39-49.

(43)

Rifoer, T. L.; Penning, T. M. Steroids 2014, 79, 49-63.

(44)

Okuwaki, M.; Tsujimoto, M.; Nagata, K. Mo/. Biol. cel/ 2002, 13, 2016-2030.

(45)

Quinlan, C. L.; Perevoshchikova, I. V.; Hey-Mogensen, M.; Orr, A L.; Brand, M.

D. Redox Biol. 2013, 1, 304-312.
(46)

Mamczur, P.; Gamian, A; Kolodziej, J.; Dziegiel, P.; Rakus, D. Biochim. et

Biophys. Acta 2013, 1833, 2812-2822.

47

(47)

Cooper, A. J. L.; Bruschi, S. A.; Iriarte, A.; Martinez-Carrion, M. Biochem. ].

2002, 368, 253-261.
(48)

Pang, Q.; Christianson, T. A.; Koretsky, T.; Carlson, H.; David, L.; Keeble, W.;

Faulkner, G. R.; Speckhart, A.; Bagby, G. C.j. Biol. Chem. 2003, 278, 41709-41717.

(49)

Gonzalez, F. A.; Raden, D. L.; Rigby, M. R.; Davis, R. J. FEBS Lett. 1992, 304,

170-178.
(50)

Banki, K.; Eddy, R. L.; Shows, T. B.; Halladay, D. L.; Bullrich, F.; Croce, C. M.;

Jurecic, V.; Baldini, A.; Perl, A. Genomics 1997, 45, 233-238.

(51) Adachi, Y.; Pavlakis, G. N.; Copeland, T. D.]. Biol. Chem. 1994, 269, 2258-2262.
(52)

Akiyama, K.; Seki, S.; Oshida, T.; Yoshida, M. C. Biochim. et Biophys. Acta 1994,

1219, 15-25.

(53)

Arakaki, T. L.; Pezza, J. A.; Cronin, M.A.; Hopkins, C. E.; Zimmer, D. B.; Tolan, D.

R.; Allen, K. N. Protein Sci.: Pub/. Protein Soc. 2004, 13, 3077-3084.

(54)

Kozu, T.; Henrich, B.; Schafer, K. P. Genomics 1995, 25, 365-371.

(55)

Fukunaga, R.; Hunter, T. EMB0].1997, 16, 1921-1933.

(56)

Bastos-Aristizabal, S.; Kozlov, G.; Gehring, K. Protein Sci. : Pub/. Protein Soc.

2014, 23, 618-626.
(57)

Duester, G. Eur.]. Biochem. / FEBS 2000, 267, 4315-4324.

(58)

Muraki, Y.; Matsumoto, I.; Chino, Y.; Hayashi, T.; Suzuki, E.; Goto, D.; Ito, S.;

Murata, H.; Tsutsumi, A.; Sumida, T. Biochem. Biophys. Res. Commun. 2004, 323, 518-

522.
(59)

Huang, K.-L.; Chadee, A. B.; Chen, C.-Y. A.; Zhang, Y.; Shyu, A.-B. RNA 2013, 19,

295-305.

48

(60)

Sennett, N. C.; Kadirvelraj, R.; Wood, Z. A. Biochemistry 2012, 51, 9364-9374.

(61)

Fu, X. Acta Biochim. et Biophys. Sin. 2014, 46, 347-356.

(62)

Vasiliou, V.; Pappa, A.; Petersen, D.R. Chem. interactions 2000, 129, 1-19.

(63)

Stover, P. J.; Chen, L. H.; Suh, J. R.; Stover, D. M.; Keyomarsi, K.; Shane, B.j. Biol.

Chem.1997,272, 1842-1848.

H.J. Hum. Genet. 2004, 49, 134-140.

(64)

Yoon, K.-A.; Nakamura, Y.; Arakawa,

(65)

Johansson, C.; Lillig, C.H.; Holmgren, A.]. Biol. Chem. 2004, 279, 7537-7543.

(66)

Pancholi, V. Cell. Mo/. life Sci.: CMLS 2001, 58, 902-920.

(67)

Walker, J. E.; Dickson, V. K. Biochim. et Biophys. Acta 2006, 1757, 286-296.

(68)

Dworniczak, 8.; Mirault, M. E. Nucleic acids Res. 1987, 15, 5181-5197.

(69)

Abedinia, M.; Layfield, R.; Jones, S. M.; Nixon, P. F.; Mattick, J. S. Biochem.

Biophys. Res. Commun. 1992, 183, 1159-1166.

(70)

Karlin, S.; Brocchieri, L.j. Mo/. Evol. 1998, 47, 565-577.

(71)

Zacharias, D. A.; Mullen, M.; Planey, S. L. Int.]. cell Biol. 2012, 2012.

(72)

Falahatpisheh, H.; Nanez, A.; Montoya-Durango, D.; Qian, Y.; Tiffany-

Castiglioni, E.; Ramos, K. S. Cell Stress &amp; Chaperon- 2007, 12, 209-218.

(73)

Fu, J.; Kreibich, G.j. Biol. Chem. 2000, 275, 3984-3990.

(7 4)

Song, Y.; Masison, D. C. ]. Biol. Chem. 2005, 280, 34178-34185.

(75)

Susin, S. A.; Lorenzo, H. K.; Zamzami, N.; Marzo, I.; Snow, B. E.; Brothers, G. M.;

Mangion, J.; Jacotot, E.; Costantini, P.; Loeffler, M.; Larochette, N.; Goodlett, D.R.;
Aebersold, R.; Siderovski, D. P.; Penninger, J. M.; Kroemer, G. Nature 1999, 397, 441-

446.
(76)

Vincendeau, M.; Nagel, D.; Brenke, J. K.; Brack-Werner, R.; Hadian, K. Viro/.j.

49

2013, 10.
(77)

Nielsen, S. V.; Poulsen, E.G.; Rebula, C. A.; Hartmann-Petersen, R.

Biomolecules 2014, 4, 646-661.

(78)

Hanahan, D.; Weinberg, R. A. Cell 2011, 144, 646-674.

50

